Toxoplasma gondii seroprevalence among pregnant women in Rabat, Morocco.
Morocco
Pregnant women
Prevalence
Rabat
Toxoplasma gondii
Toxoplasmosis
Journal
Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093
Informations de publication
Date de publication:
08 Mar 2021
08 Mar 2021
Historique:
received:
23
12
2020
accepted:
22
02
2021
entrez:
9
3
2021
pubmed:
10
3
2021
medline:
10
3
2021
Statut:
epublish
Résumé
Toxoplasmosis is an infectious disease caused by a protozoan parasite named Toxoplasma gondii (T.gondii). Pregnant women are considered one of the risk groups. The objective of this retrospective study is to provide an updated estimate of the seroprevalence of anti-T. gondii antibodies among a group of Moroccan pregnant women monitored at the Parasitology Laboratory of the National Institute of Hygiene in Rabat in Morocco. Serum samples were tested for the presence of specific anti-T. gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies using indirect enzyme-linked immunosorbent assay (ELISA). Anti-Toxoplasma IgM- and IgG-positive cases were also evaluated with the anti-Toxoplasma IgG avidity test. All cases were evaluated according to the age, parity, and historical of abortion. Among 677 pregnant women, 94.1% (637/677) were serologically screened for the first time and therefore had no knowledge of their serological status, and only 5.9% (40/677) were screened for the second or third time. The overall anti-T. gondii IgG and IgM seropositivity among the 637 pregnant women included in the study analysis was 43% (274/637) and 3.9% (25/637), respectively. The use of the IgG avidity test allowed excluding recent infection among 83% of cases with IgG and IgM positive sera. The mean age was 29.4 ± 6.3 years. The result of the bivariate analysis revealed that the age influenced significantly the seroprevalence rate, while the parity and the existence of previous spontaneous abortion did not have any significant statistical correlation with seropositivity to T. gondii. This study shows that 43% of pregnant women were positive and 57% of them had no antibody against the T. gondii infection. However, the pregnancy follow-up and the counseling of pregnant women remain essential for the prevention of congenital toxoplasmosis.
Sections du résumé
BACKGROUND
BACKGROUND
Toxoplasmosis is an infectious disease caused by a protozoan parasite named Toxoplasma gondii (T.gondii). Pregnant women are considered one of the risk groups. The objective of this retrospective study is to provide an updated estimate of the seroprevalence of anti-T. gondii antibodies among a group of Moroccan pregnant women monitored at the Parasitology Laboratory of the National Institute of Hygiene in Rabat in Morocco.
METHODS
METHODS
Serum samples were tested for the presence of specific anti-T. gondii immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies using indirect enzyme-linked immunosorbent assay (ELISA). Anti-Toxoplasma IgM- and IgG-positive cases were also evaluated with the anti-Toxoplasma IgG avidity test. All cases were evaluated according to the age, parity, and historical of abortion.
RESULTS
RESULTS
Among 677 pregnant women, 94.1% (637/677) were serologically screened for the first time and therefore had no knowledge of their serological status, and only 5.9% (40/677) were screened for the second or third time. The overall anti-T. gondii IgG and IgM seropositivity among the 637 pregnant women included in the study analysis was 43% (274/637) and 3.9% (25/637), respectively. The use of the IgG avidity test allowed excluding recent infection among 83% of cases with IgG and IgM positive sera. The mean age was 29.4 ± 6.3 years. The result of the bivariate analysis revealed that the age influenced significantly the seroprevalence rate, while the parity and the existence of previous spontaneous abortion did not have any significant statistical correlation with seropositivity to T. gondii.
CONCLUSION
CONCLUSIONS
This study shows that 43% of pregnant women were positive and 57% of them had no antibody against the T. gondii infection. However, the pregnancy follow-up and the counseling of pregnant women remain essential for the prevention of congenital toxoplasmosis.
Identifiants
pubmed: 33685529
doi: 10.1186/s41182-021-00311-5
pii: 10.1186/s41182-021-00311-5
pmc: PMC7941977
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21Références
Vector Borne Zoonotic Dis. 2017 Dec;17(12):785-790
pubmed: 29064352
Euro Surveill. 2016 Aug 18;21(33):
pubmed: 27562876
Rev Soc Bras Med Trop. 2020 Mar 16;53:e20190164
pubmed: 32187332
BMC Res Notes. 2019 May 16;12(1):279
pubmed: 31097016
Parasite. 2009 Mar;16(1):71-2
pubmed: 19353955
Ann Biol Clin (Paris). 1998 Sep-Oct;56(5):586-9
pubmed: 9769488
Int J Parasitol. 2009 Oct;39(12):1385-94
pubmed: 19433092
BMC Infect Dis. 2019 Apr 16;19(1):327
pubmed: 30991956
J Pediatr Infect Dis. 2017 Dec;12(4):202-208
pubmed: 29230092
Parasitology. 2012 Sep;139(11):1375-424
pubmed: 22776427
Turkiye Parazitol Derg. 2018 Jun;42(2):101-105
pubmed: 29780008
Handb Clin Neurol. 2013;114:125-45
pubmed: 23829904
Acta Trop. 2017 Aug;172:139-142
pubmed: 28433574
Bull Soc Pathol Exot. 2019;112(2):79-89
pubmed: 31478622
Vector Borne Zoonotic Dis. 2020 Oct;20(10):763-767
pubmed: 32589521
Trop Med Health. 2018 Nov 19;46:39
pubmed: 30479556
J Parasit Dis. 2018 Dec;42(4):554-558
pubmed: 30538353
Trop Med Health. 2020 Apr 09;48:17
pubmed: 32292287
Eur J Epidemiol. 1997 Jul;13(5):567-71
pubmed: 9258570
Pan Afr Med J. 2017 Aug 10;27:269
pubmed: 29187938
Rev Epidemiol Sante Publique. 2009 Aug;57(4):241-8
pubmed: 19577390
Bull Soc Pathol Exot. 2013 May;106(2):108-12
pubmed: 23576025
Clin Microbiol Rev. 2012 Apr;25(2):264-96
pubmed: 22491772
Trop Med Health. 2020 May 19;48:35
pubmed: 32467660
Parasite. 2020;27:2
pubmed: 31934847
Rev Epidemiol Sante Publique. 2014 Apr;62(2):160-5
pubmed: 24661506